We canβt show the full text here under this license. Use the link below to read it at the source.
Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017β2020
Links between blood inflammation markers and metabolism-related fatty liver disease in US adults
AI simplified
Abstract
Among 6613 adults, specific systemic inflammatory biomarkers are significantly associated with metabolic dysfunction-associated steatotic liver disease () risk.
- and are negatively associated with MASLD risk, while , , and show a positive association.
- Most biomarkers, including ALI, SIRI, IBI, CAR, LMR, and PNI, have significant non-linear correlations with MASLD.
- Age-related differences significantly influence the association between ALI and MASLD risk.
- Variations in the relationship between PNI and MASLD risk are observed across different cardiovascular outcomes.
AI simplified
Key numbers
29.8β45.2%
Prevalence of
Estimated prevalence range of in the United States.
6613 adults
Study Population Size
Total number of adults assessed in the NHANES study.
34.67% aged 40-59 years
Age Group Proportion
Percentage of participants in the 40-59 age group.